COLUMBUS 5-Year Update: a Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients with BRAF.Reinhard Dummer,Keith T Flaherty,Caroline Robert,Ana Arance,Jan Willem B de Groot,Claus Garbe,Helen J Gogas,Ralf Gutzmer,Ivana Krajsová,Gabriella Liszkay,Carmen Loquai,Mario Mandalà,Dirk Schadendorf,Naoya Yamazaki,Alessandra di Pietro,Jean Cantey-Kiser,Michelle Edwards,Paolo A AsciertoFuture oncology(2023)引用 48|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要